Targeted DNA RNA Sequencing Market Size, Share, Trends, Industry Analysis Report: By Type, Method, Workflow, End User, and Region

Description

List of Tables

The global targeted DNA RNA sequencing market size is expected to reach USD 70.79 billion by 2034, according to a new study by Polaris Market Research. The report "Targeted DNA RNA Sequencing Market Size, Share, Trends, Industry Analysis Report: By Type (DNA-Based and RNA-Based), Method, Workflow, End User (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The targeted DNA/RNA sequencing market is experiencing robust growth, driven by advancements in next-generation sequencing (NGS) technologies, increasing demand for personalized medicine, and the rising prevalence of genetic disorders and cancer. The market benefits from opportunities in drug discovery, companion diagnostics, and the expanding application of sequencing in clinical settings.

The integration of AI and bioinformatics for data analysis, the development of cost-effective sequencing platforms, and growing interest in single-cell sequencing are expected to emerge as key trends in the market during the forecast period. Overall, the market is set for substantial expansion, underpinned by continuous innovation and the broader adoption of precision medicine.

Targeted DNA RNA Sequencing Market Report Highlights

Based on type, the DNA-based segment dominates the market due to its extensive application in clinical diagnostics and research. The RNA-based segment is witnessing rapid growth, driven by its increasing use in transcriptomics and gene expression studies.

The exome sequencing segment, by method, leads the market, as it is widely adopted for identifying genetic variations linked to diseases. However, the amplicon sequencing segment is gaining traction for its cost-effectiveness and targeted approach, particularly in cancer research.

The sequencing segment, in terms of workflow, holds the largest market share, benefiting from technological advancements and reduced costs. Data analysis is the fastest-growing segment, propelled by the need for robust bioinformatics tools to handle complex sequencing data.

By end user, the academic research segment holds the largest market share due to ongoing genomic studies and research funding. The pharma & biotech entities segment is the fastest-growing segment, leveraging sequencing for drug development and personalized medicine.

North America dominates the market, driven by advanced healthcare infrastructure and significant R&D investments. Asia Pacific is the fastest-growing region, with increasing adoption of sequencing technologies in emerging economies such as China and India.

Polaris Market Research has segmented the targeted DNA RNA sequencing market report on the basis of type, method, workflow, end user, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

DNA-Based
RNA-Based

By Method Outlook (Revenue - USD Billion, 2020-2034)

Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Others

By Workflow Outlook (Revenue - USD Billion, 2020-2034)

Pre-sequencing
Sequencing
Data Analysis

By End User Outlook (Revenue - USD Billion, 2020-2034)

Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5244

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Targeted DNA RNA Sequencing Market Insights

4.1. Targeted DNA RNA Sequencing Market - Market Snapshot
4.2. Targeted DNA RNA Sequencing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancements in Sequencing Technologies
  - 4.2.1.2. Expansion in Oncology Research
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. The high cost and intensive process for assay design.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Targeted DNA RNA Sequencing Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Targeted DNA RNA Sequencing Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
5.3. DNA-Based
- 5.3.1. Global Targeted DNA RNA Sequencing Market, by DNA-Based, by Region, 2020-2034 (USD Billion)
5.4. RNA-Based
- 5.4.1. Global Targeted DNA RNA Sequencing Market, by RNA-Based, by Region, 2020-2034 (USD Billion)

6. Global Targeted DNA RNA Sequencing Market, by Method

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
6.3. Exome Sequencing
- 6.3.1. Global Targeted DNA RNA Sequencing Market, by Exome Sequencing, by Region, 2020-2034 (USD Billion)
6.4. Enrichment Sequencing
- 6.4.1. Global Targeted DNA RNA Sequencing Market, by Enrichment Sequencing, by Region, 2020-2034 (USD Billion)
6.5. Amplicon Sequencing
- 6.5.1. Global Targeted DNA RNA Sequencing Market, by Amplicon Sequencing, by Region, 2020-2034 (USD Billion)
6.6. Others
- 6.6.1. Global Targeted DNA RNA Sequencing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Targeted DNA RNA Sequencing Market, by Workflow

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
7.3. Pre-sequencing
- 7.3.1. Global Targeted DNA RNA Sequencing Market, by Pre-sequencing, by Region, 2020-2034 (USD Billion)
7.4. Sequencing
- 7.4.1. Global Targeted DNA RNA Sequencing Market, by Sequencing, by Region, 2020-2034 (USD Billion)
7.5. Data Analysis
- 7.5.1. Global Targeted DNA RNA Sequencing Market, by Data Analysis, by Region, 2020-2034 (USD Billion)

8. Global Targeted DNA RNA Sequencing Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
8.3. Academic Research
- 8.3.1. Global Targeted DNA RNA Sequencing Market, by Academic Research, by Region, 2020-2034 (USD Billion)
8.4. Hospitals & Clinics
- 8.4.1. Global Targeted DNA RNA Sequencing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
8.5. Pharma & Biotech Entities
- 8.5.1. Global Targeted DNA RNA Sequencing Market, by Pharma & Biotech Entities, by Region, 2020-2034 (USD Billion)
8.6. Others
- 8.6.1. Global Targeted DNA RNA Sequencing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Targeted DNA RNA Sequencing Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Targeted DNA RNA Sequencing Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Targeted DNA RNA Sequencing Market - North America
- 9.3.1. North America: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
- 9.3.3. North America: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
- 9.3.4. North America: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.3.5. Targeted DNA RNA Sequencing Market - US
  - 9.3.5.1. US: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.3.6. Targeted DNA RNA Sequencing Market - Canada
  - 9.3.6.1. Canada: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
9.4. Targeted DNA RNA Sequencing Market - Europe
- 9.4.1. Europe: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
- 9.4.3. Europe: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.4. Europe: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.4.5. Targeted DNA RNA Sequencing Market - UK
  - 9.4.5.1. UK: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.4.6. Targeted DNA RNA Sequencing Market - France
  - 9.4.6.1. France: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.4.7. Targeted DNA RNA Sequencing Market - Germany
  - 9.4.7.1. Germany: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.4.8. Targeted DNA RNA Sequencing Market - Italy
  - 9.4.8.1. Italy: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.4.9. Targeted DNA RNA Sequencing Market - Spain
  - 9.4.9.1. Spain: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.4.10. Targeted DNA RNA Sequencing Market - Netherlands
  - 9.4.10.1. Netherlands: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.4.11. Targeted DNA RNA Sequencing Market - Russia
  - 9.4.11.1. Russia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.4.12. Targeted DNA RNA Sequencing Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
9.5. Targeted DNA RNA Sequencing Market - Asia Pacific
- 9.5.1. Asia Pacific: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.5.5. Targeted DNA RNA Sequencing Market - China
  - 9.5.5.1. China: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.5.6. Targeted DNA RNA Sequencing Market - India
  - 9.5.6.1. India: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.5.7. Targeted DNA RNA Sequencing Market - Malaysia
  - 9.5.7.1. Malaysia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.5.8. Targeted DNA RNA Sequencing Market - Japan
  - 9.5.8.1. Japan: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.5.9. Targeted DNA RNA Sequencing Market - Indonesia
  - 9.5.9.1. Indonesia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.5.10. Targeted DNA RNA Sequencing Market - South Korea
  - 9.5.10.1. South Korea: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.5.11. Targeted DNA RNA Sequencing Market - Australia
  - 9.5.11.1. Australia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.5.12. Targeted DNA RNA Sequencing Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
9.6. Targeted DNA RNA Sequencing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.6.5. Targeted DNA RNA Sequencing Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.6.6. Targeted DNA RNA Sequencing Market - UAE
  - 9.6.6.1. UAE: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.6.7. Targeted DNA RNA Sequencing Market - Israel
  - 9.6.7.1. Israel: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.6.8. Targeted DNA RNA Sequencing Market - South Africa
  - 9.6.8.1. South Africa: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.6.9. Targeted DNA RNA Sequencing Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
9.7. Targeted DNA RNA Sequencing Market - Latin America
- 9.7.1. Latin America: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.7.5. Targeted DNA RNA Sequencing Market - Mexico
  - 9.7.5.1. Mexico: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.7.6. Targeted DNA RNA Sequencing Market - Brazil
  - 9.7.6.1. Brazil: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.7.7. Targeted DNA RNA Sequencing Market - Argentina
  - 9.7.7.1. Argentina: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)
- 9.7.8. Targeted DNA RNA Sequencing Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Targeted DNA RNA Sequencing Market, by Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Targeted DNA RNA Sequencing Market, by Method, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Targeted DNA RNA Sequencing Market, by Workflow, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Targeted DNA RNA Sequencing Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Illumina Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Thermo Fisher Scientific
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Agilent Technologies
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Roche Sequencing Solutions
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. QIAGEN
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Pacific Biosciences
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Oxford Nanopore Technologies
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. BGI Genomics
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Genomatix Software
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Bio-Rad Laboratories
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. PerkinElmer
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Hudon Alpha
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Element Biosciences
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Twist Bioscience
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Nextera
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development